Filing Details
- Accession Number:
- 0001209191-14-067770
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-11-10 21:17:26
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-11-10
- Accepted Time:
- 2014-11-10 21:17:26
- Original Submission Date:
- 2014-09-03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380185 | Fuad El-Hibri | 2273 Research Blvd., Suite 400 Rockville MD 20850 | Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-09-02 | 1,633 | $25.00 | 14,212 | No | 4 | S | Indirect | By Yusra El-Hibri Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Yusra El-Hibri Trust |
Footnotes
- This amendment to the Form 4 previously filed on September 2, 2014 is to correct the transaction code from "F" to "S".
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 10, 2014.
- These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
